Evaluation Of The Efficacy And Safety Of Single Doses Of PF-05089771 In Patients With Primary (Inherited) Erythromelalgia
Clinical trial NCT01769274 · COMPLETED
Trial details
- NCT number
- NCT01769274
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-22
- Primary completion
- 2013-07-12
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.